Navigation Links
Ardea Biosciences Announces $40 Million Private Placement
Date:12/20/2007

should not be regarded as a representation by Ardea that any future events will occur. There are a number of important factors that could cause Ardea's results to differ materially from those indicated by these forward-looking statements, including risks associated with the satisfaction of the closing conditions to the closing of the private placement and the risks and uncertainties described more fully in Ardea's most recently filed SEC documents, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. Ardea undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
4. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
7. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
8. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...at Queen,s University Belfast are developing new s... which will help in the fight against the threat o...ial gel pads to ,swipe, an individual or crime sce...scanning instrument that can detect the presence o..., faster decisions to be made in response to terro...
(Date:11/18/2009)... Vernier,s experience in data analysis combined wi...am kits and curricula provide state-of-the...BEAVERTON, Ore., Nov. 18 Vernier S...l science interfaces, sensors, and software and Bi...urer and distributor of life science research and ...
(Date:11/18/2009)...ST GRINSTEAD, West Sussex, U.K. and CLEVELAND, Nov...gellan Biosciences business and premier provider o...or microbiology labs, has expanded its East Grinst...ent facility to meet increasing global demand for ...ty and identification testing. The expanded facili...
(Date:11/18/2009)...SISSAUGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM ...fe sciences product development company that ident...g cancer-related products at various stages of dev...uating nimotuzumab were presented today in a poste... Cancer Therapeutics conference in Boston, Massach...
Breaking Biology Technology:New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
... DNA2.0 has designed RNAi-resistant ge...he inner workings of the cell cycle. DNA2.0,s RNAi...ession in the desired host and to escape inhibitio..., Menlo Park, Calif. (PRWE...tic genomics company, announced today that the com...
...akes up nearly 23% of fund raising goal for Centra...ompany,(NYSE: LLY ) President and Chief Executive...million check to the United Way of Central Indiana...aising campaigns. The check,represents the contrib...United States with a matching gift amount from the...
...NG, Pa., Nov. 13 Genaera,Corporation (Nasdaq: GE...vember 17-19 at the Congress Center in Mannheim, G...and Chief Scientific Officer, will present,a compa... a.m. CET., About Genaera, Genaera Corporation i...iabetes and obesity currently in phase 1 clinical ...
Other Biology Technology:RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research 2RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research 3Lilly Contributes $11.1 Million to United Way Annual Campaign 2Genaera to Present at BIO-Europe 2008 2
(Date:11/20/2009)...asurements of plasma lipoprotein concentrations de...y (NMR), researchers led by Daniel Chasman at Brig...l in Boston, MA, the Framingham Heart Study in Fra..., Sweden and Oxford, England performed genetic ass...,296 women of European ancestry from the Women,s G...
(Date:11/20/2009)...ovember 19, 2009 The estimated 4.6 million Americ... of developing respiratory symptoms due to poor ai...aire study undertaken earlier this year by investi...terinary Medicine. , The studywhich polled more ...0 percent of individuals working in barns complain...
(Date:11/20/2009)...e production of flax shives, and generated from B... to those which engulf fields in spring, can be us...by two studies carried out by Spanish and Dutch re...and Sustainable Energy Reviews . , "These studies...e production of bioethanol from two, as yet unexpl...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Flax and yellow flowers can produce bioethanol 2Amgens Denosumab and Eli Lillys Forteo Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018 47435 1Amgens Denosumab and Eli Lillys Forteo Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018 47435 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 12374 1Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 12374 2Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 12374 3
...e evolutionary paths some 5 million to 6 million y... mastered bipedal locomotion, and acquired a knack...d to use tools, and developed the skills to constr...We differ by just a tad over 1% at the DNA sequenc...should harbor genetic footprints of our divergence...
...n time, what causes those variations, and how sens...orestation is a focus of study for scientists at t...lopment pressures in the last several decades have...Amazon, most in the eastern and southern portion o...odels and data from several disciplines to assess ...
... greenbug or rust in wheat may require some bridge... at the Texas A&M University System Agricultur...reeder, is looking at wild grass species and synth...ng for new unique sources of resistance to various...ng forced to find broader gene pools to bring in t...
Other Biology News:Can our genes tell the story of our divergence? 2Assessing the Amazon River's sensitivity to deforestation 2Wild grasses and man-made wheats advance research capabilities 2Wild grasses and man-made wheats advance research capabilities 3
...EtBr Spin Columns provide a rapid and simple metho... (100 bp to 10 kb) from stained agarose gels or Et...rom an agarose gel and loaded into the spin column...ies of membranes and filters that hold agarose and...
...nables efficient extraction of DNA fragments from ...he procedure uses GelMelt solution to dissolve the... silica membrane in a spin column format. After a ...buffer. Each spin column can bind up to 20 g DNA. ...
StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
...ed by end-users to be "a delight to use" as it inc... electronic imaging. With its ergonomic design and...nd can easily be accommodated in a busy lab enviro...nary Colour Corrected Infinity System and infinity...
Biology Products: